{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:29:16Z","timestamp":1794832156121,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-025-01594-3","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:02:15Z","timestamp":1768989735000},"page":"815-831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lung tumouroids as a testing platform for precision CAR T cell therapy"],"prefix":"10.1038","volume":"10","author":[{"given":"Lukas","family":"Ehlen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00ed","family":"Farrera-Sal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Szyska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Schallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vollbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"L\u00f6wa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-7445","authenticated-orcid":false,"given":"Lena","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Picht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Schulenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Geray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Korus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Sommerfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Treue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Strauchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Elsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-7978","authenticated-orcid":false,"given":"Jonas","family":"Kath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Fernandez","family":"Vallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-228X","authenticated-orcid":false,"given":"Franka","family":"Klatte-Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9283-4605","authenticated-orcid":false,"given":"Harald","family":"Stachelscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2189-3579","authenticated-orcid":false,"given":"Dimitrios L.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Spies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Carsten","family":"R\u00fcckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6935-8612","authenticated-orcid":false,"given":"Andreas C.","family":"Hocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4727-2540","authenticated-orcid":false,"given":"Julia K.","family":"Polansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7693-799X","authenticated-orcid":false,"given":"Regina","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5964-9179","authenticated-orcid":false,"given":"Michael","family":"Schmueck-Henneresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"1594_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1594_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1594_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-019-0818-2","volume":"12","author":"Z-F Lim","year":"2019","unstructured":"Lim, Z.-F. & Ma, P. C. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy. J. Hematol. Oncol. 12, 134 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"1594_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda, S. M. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat. Rev. Clin. Oncol. 21, 47\u201366 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1594_CR5","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1158\/2159-8290.CD-21-0407","volume":"11","author":"PS Adusumilli","year":"2021","unstructured":"Adusumilli, P. S. et al. A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti\u2013PD-1 agent pembrolizumab. Cancer Discov. 11, 2748\u20132763 (2021).","journal-title":"Cancer Discov."},{"key":"1594_CR6","doi-asserted-by":"publisher","first-page":"782775","DOI":"10.3389\/fimmu.2021.782775","volume":"12","author":"B-F Xiao","year":"2021","unstructured":"Xiao, B.-F. et al. Chimeric antigen receptor T-cell therapy in lung cancer: potential and challenges. Front. Immunol. 12, 782775 (2021).","journal-title":"Front. Immunol."},{"key":"1594_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.gde.2013.11.012","volume":"24","author":"N Sachs","year":"2014","unstructured":"Sachs, N. & Clevers, H. Organoid cultures for the analysis of cancer phenotypes. Curr. Opin. Genet. Dev. 24, 68\u201373 (2014).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"1594_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s44222-023-00063-3","volume":"1","author":"A Loewa","year":"2023","unstructured":"Loewa, A., Feng, J. J. & Hedtrich, S. Human disease models in drug development. Nat. Rev. Bioeng. 1, 545\u2013559 (2023).","journal-title":"Nat. Rev. Bioeng."},{"key":"1594_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper, O. et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat. Med. 25, 838\u2013849 (2019).","journal-title":"Nat. Med."},{"key":"1594_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373\u2013386.e10 (2018).","journal-title":"Cell"},{"key":"1594_CR11","doi-asserted-by":"publisher","first-page":"26580","DOI":"10.1073\/pnas.1911273116","volume":"116","author":"E Driehuis","year":"2019","unstructured":"Driehuis, E. et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc. Natl Acad. Sci. USA 116, 26580\u201326590 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1594_CR12","doi-asserted-by":"publisher","first-page":"107588","DOI":"10.1016\/j.celrep.2020.107588","volume":"31","author":"KK Dijkstra","year":"2020","unstructured":"Dijkstra, K. K. et al. Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine. Cell Rep. 31, 107588 (2020).","journal-title":"Cell Rep."},{"key":"1594_CR13","first-page":"1","volume":"5","author":"E Yokota","year":"2021","unstructured":"Yokota, E. et al. Clinical application of a lung cancer organoid (TO) culture system. npj Precis. Oncol. 5, 1\u201312 (2021).","journal-title":"npj Precis. Oncol."},{"key":"1594_CR14","doi-asserted-by":"publisher","first-page":"112212","DOI":"10.1016\/j.celrep.2023.112212","volume":"42","author":"T Ebisudani","year":"2023","unstructured":"Ebisudani, T. et al. Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma. Cell Rep. 42, 112212 (2023).","journal-title":"Cell Rep."},{"key":"1594_CR15","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","volume":"26","author":"R Shi","year":"2020","unstructured":"Shi, R. et al. Organoid cultures as preclinical models of non-small cell lung cancer. Clin. Cancer Res. 26, 1162\u20131174 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1594_CR16","doi-asserted-by":"publisher","first-page":"eaay2574","DOI":"10.1126\/scitranslmed.aay2574","volume":"11","author":"SN Ooft","year":"2019","unstructured":"Ooft, S. N. et al. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Sci. Transl. Med. 11, eaay2574 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1594_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","volume":"26","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell Stem Cell 26, 17\u201326 (2020).","journal-title":"Cell Stem Cell"},{"key":"1594_CR18","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.xcrm.2023.101335","volume":"4","author":"T Tan","year":"2023","unstructured":"Tan, T. et al. Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer. Cell Rep. Med. 4, 101335 (2023).","journal-title":"Cell Rep. Med."},{"key":"1594_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22676-1","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week. Nat. Commun. 12, 2581 (2021).","journal-title":"Nat. Commun."},{"key":"1594_CR20","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1073\/pnas.1015938108","volume":"108","author":"J Kondo","year":"2011","unstructured":"Kondo, J. et al. Retaining cell\u2013cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer. Proc. Natl Acad. Sci. USA 108, 6235\u20136240 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1594_CR21","doi-asserted-by":"publisher","first-page":"103610","DOI":"10.1016\/j.critrevonc.2022.103610","volume":"171","author":"H Ma","year":"2022","unstructured":"Ma, H. et al. Lung cancer organoids, a promising model still with long way to go. Crit. Rev. Oncol. Hematol. 171, 103610 (2022).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1594_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41577-019-0248-y","volume":"20","author":"YE Bar-Ephraim","year":"2020","unstructured":"Bar-Ephraim, Y. E., Kretzschmar, K. & Clevers, H. Organoids in immunological research. Nat. Rev. Immunol. 20, 279\u2013293 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1594_CR23","doi-asserted-by":"publisher","first-page":"e100300","DOI":"10.15252\/embj.2018100300","volume":"38","author":"N Sachs","year":"2019","unstructured":"Sachs, N. et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 38, e100300 (2019).","journal-title":"EMBO J."},{"key":"1594_CR24","doi-asserted-by":"publisher","first-page":"216022","DOI":"10.1016\/j.canlet.2022.216022","volume":"554","author":"Y Tian","year":"2023","unstructured":"Tian, Y., Xu, L., Li, X., Li, H. & Zhao, M. SMARCA4: current status and future perspectives in non-small-cell lung cancer. Cancer Lett. 554, 216022 (2023).","journal-title":"Cancer Lett."},{"key":"1594_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.lungcan.2019.05.002","volume":"134","author":"JA Hellyer","year":"2019","unstructured":"Hellyer, J. A. et al. Impact of KEAP1\/NFE2L2\/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer. Lung Cancer 134, 42\u201345 (2019).","journal-title":"Lung Cancer"},{"key":"1594_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/boc.201800050","volume":"111","author":"E Madden","year":"2019","unstructured":"Madden, E., Logue, S. E., Healy, S. J., Manie, S. & Samali, A. The role of the unfolded protein response in cancer progression: from oncogenesis to chemoresistance. Biol. Cell 111, 1\u201317 (2019).","journal-title":"Biol. Cell"},{"key":"1594_CR27","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1111\/bph.15420","volume":"179","author":"FM Healy","year":"2022","unstructured":"Healy, F. M., Prior, I. A. & MacEwan, D. J. The importance of Ras in drug resistance in cancer. Br. J. Pharmacol. 179, 2844\u20132867 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"1594_CR28","doi-asserted-by":"publisher","first-page":"eadd3243","DOI":"10.1126\/sciadv.add3243","volume":"9","author":"LJ Eichner","year":"2023","unstructured":"Eichner, L. J. et al. HDAC3 is critical in tumor development and therapeutic resistance in Kras -mutant non\u2013small cell lung cancer. Sci. Adv. 9, eadd3243 (2023).","journal-title":"Sci. Adv."},{"key":"1594_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1019-6","volume":"9","author":"C-Y Huang","year":"2018","unstructured":"Huang, C.-Y. et al. HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer. Cell Death Dis. 9, 1004 (2018).","journal-title":"Cell Death Dis."},{"key":"1594_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/onc.2011.290","volume":"31","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene 31, 1055\u20131064 (2012).","journal-title":"Oncogene"},{"key":"1594_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.omtm.2022.03.018","volume":"25","author":"J Kath","year":"2022","unstructured":"Kath, J. et al. Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells. Mol. Ther. Methods Clin. Dev. 25, 311\u2013330 (2022).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1594_CR32","doi-asserted-by":"publisher","first-page":"113424","DOI":"10.1016\/j.celrep.2023.113424","volume":"42","author":"F Xu","year":"2023","unstructured":"Xu, F. et al. Prostate cancer cell-derived exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8+\u2009T cell. Cell Rep. 42, 113424 (2023).","journal-title":"Cell Rep."},{"key":"1594_CR33","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1182\/blood-2022-168590","volume":"140","author":"H Mei","year":"2022","unstructured":"Mei, H. et al. Autophagy facilitates cancer-intrinsic evasion of CAR T cell-mediated cytotoxicity in B-cell malignancies. Blood 140, 634\u2013635 (2022).","journal-title":"Blood"},{"key":"1594_CR34","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41586-024-07113-9","volume":"627","author":"G Han","year":"2024","unstructured":"Han, G. et al. An atlas of epithelial cell states and plasticity in lung adenocarcinoma. Nature 627, 656\u2013663 (2024).","journal-title":"Nature"},{"key":"1594_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","volume":"31","author":"MMA Verstegen","year":"2025","unstructured":"Verstegen, M. M. A. et al. Clinical applications of human organoids. Nat. Med. 31, 409\u2013421 (2025).","journal-title":"Nat. Med."},{"key":"1594_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47799-z","volume":"15","author":"I Andreu-Saumell","year":"2024","unstructured":"Andreu-Saumell, I. et al. CAR affinity modulates the sensitivity of CAR-T cells to PD-1\/PD-L1-mediated inhibition. Nat. Commun. 15, 3552 (2024).","journal-title":"Nat. Commun."},{"key":"1594_CR37","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41375-020-01085-1","volume":"35","author":"Z Jiang","year":"2021","unstructured":"Jiang, Z. et al. IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells. Leukemia 35, 1380\u20131391 (2021).","journal-title":"Leukemia"},{"key":"1594_CR38","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-19-0945","volume":"10","author":"RG Majzner","year":"2020","unstructured":"Majzner, R. G. et al. Tuning the antigen density requirement for CAR T cell activity. Cancer Discov. 10, 702\u2013723 (2020).","journal-title":"Cancer Discov."},{"key":"1594_CR39","doi-asserted-by":"publisher","first-page":"1321596","DOI":"10.3389\/fimmu.2023.1321596","volume":"14","author":"DC Harrer","year":"2023","unstructured":"Harrer, D. C. et al. Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges. Front. Immunol. 14, 1321596 (2023).","journal-title":"Front. Immunol."},{"key":"1594_CR40","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s41591-021-01436-0","volume":"27","author":"JY Spiegel","year":"2021","unstructured":"Spiegel, J. Y. et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat. Med. 27, 1419\u20131431 (2021).","journal-title":"Nat. Med."},{"key":"1594_CR41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/mt.2010.24","volume":"18","author":"RA Morgan","year":"2010","unstructured":"Morgan, R. A. et al. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol. Ther. J. Am. Soc. Gene Ther. 18, 843\u2013851 (2010).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"1594_CR42","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1038\/nprot.2013.153","volume":"8","author":"H Miyoshi","year":"2013","unstructured":"Miyoshi, H. & Stappenbeck, T. S. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat. Protoc. 8, 2471\u20132482 (2013).","journal-title":"Nat. Protoc."},{"key":"1594_CR43","doi-asserted-by":"publisher","first-page":"120247","DOI":"10.1016\/j.biomaterials.2020.120247","volume":"257","author":"A Daneshgar","year":"2020","unstructured":"Daneshgar, A. et al. The human liver matrisome\u2014proteomic analysis of native and fibrotic human liver extracellular matrices for organ engineering approaches. Biomaterials 257, 120247 (2020).","journal-title":"Biomaterials"},{"key":"1594_CR44","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/imt2.43","volume":"1","author":"Z Gu","year":"2022","unstructured":"Gu, Z. Complex heatmap visualization. iMeta 1, e43 (2022).","journal-title":"iMeta"},{"key":"1594_CR45","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. circlize implements and enhances circular visualization in R. Bioinformatics 30, 2811\u20132812 (2014).","journal-title":"Bioinformatics"},{"key":"1594_CR46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"J-P Fortin","year":"2017","unstructured":"Fortin, J.-P., Triche, T. J. & Hansen, K. D. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics 33, 558\u2013560 (2017).","journal-title":"Bioinformatics"},{"key":"1594_CR47","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1594_CR48","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"1594_CR49","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1074\/mcp.TIR120.002155","volume":"19","author":"J Griss","year":"2020","unstructured":"Griss, J. et al. ReactomeGSA\u2014efficient multi-omics comparative pathway analysis. Mol. Cell. Proteomics 19, 2115\u20132125 (2020).","journal-title":"Mol. Cell. Proteomics"},{"key":"1594_CR50","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/bioinformatics\/btv701","volume":"32","author":"A Luna","year":"2016","unstructured":"Luna, A. et al. rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R. Bioinformatics 32, 1272\u20131274 (2016).","journal-title":"Bioinformatics"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01594-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:02:32Z","timestamp":1776808952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01594-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1594"],"URL":"https:\/\/doi.org\/10.1038\/s41551-025-01594-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5418471\/v1","asserted-by":"object"}]},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}